Rezolute's Keith Vendola Presents at 2020 Biotech Showcase in San Francisco Transcript
Good morning. Our first presentation this morning is from Rezolute from Redwood City, California, United States. Rezolute is focused on orphan rare diseases, endocrine metabolic. Presenting for Rezolute is their CFO, Keith Vendola. Thank you very much.
Thank you for having me here today. What a beautiful city, what a fantastic conference, what a great way to kick off the new year. I'm Keith Vendola, the CFO of Rezolute. It's a pleasure to be here.
We all like stories. And how about we start off with a little story? Imagine you have a child. And imagine that for the past several years, you and he had been in and out of hospitals. Together, you have been navigating with a sports team of providers: endocrinologists, pediatricians, radiologists, surgeons, dietitians, neuro development experts and social workers, to name a few.
The doctors have done workups and run blood tests. They have told you certain genetic mutations within your child's pancreas are causing him problems. His beta cells are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |